Quantitative coronary angiography versus intravascular ultrasound guidance for drug-eluting stent implantation (GUIDE-DES): study protocol for a randomised controlled non-inferiority trial

被引:10
|
作者
Lee, Pil Hyung [1 ]
Hong, Soon Jun [2 ]
Kim, Hyun-Sook [3 ]
Yoon, Young Won [4 ]
Lee, Jong-Young [5 ]
Oh, Seung-Jin [6 ]
Kang, Soo-Jin [1 ]
Kim, Young-Hak [1 ]
Park, Seong-Wook [1 ]
Lee, Seung-Whan [1 ]
Lee, Cheol Whan [1 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Dept Internal Med, Div Cardiol,Coll Med, Seoul, South Korea
[2] Korea Univ, Cardiovasc Ctr, Dept Cardiol, Anam Hosp, Seoul, South Korea
[3] Hallym Univ, Dept Cardiol, Sacred Heart Hosp, Anyang, South Korea
[4] Yonsei Univ, Gangnam Severance Hosp, Div Cardiol, Coll Med, Seoul, South Korea
[5] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Div Cardiol,Sch Med, Seoul, South Korea
[6] Natl Hlth Insurance Serv Ilsan Hosp, Dept Cardiol, Gyeonggi Do, South Korea
来源
BMJ OPEN | 2022年 / 12卷 / 01期
关键词
CARDIOVASCULAR ANGIOGRAPHY; MYOCARDIAL-INFARCTION; IVUS; OUTCOMES; INTERVENTION; METAANALYSIS; PREDICTORS; LESIONS; REVASCULARIZATION; DEFINITION;
D O I
10.1136/bmjopen-2021-052215
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Angiography remains the gold standard for guiding percutaneous coronary intervention (PCI). However, it is prone to suboptimal stent results due to the visual estimation of coronary measurements. Although the benefit of intravascular ultrasound (IVUS)-guided PCI is becoming increasingly recognised, IVUS is not affordable for many catheterisation laboratories. Thus, a more practical and standardised angiography-based approach is necessary to support stent implantation. Methods and analysis The Quantitative Coronary Angiography versus Intravascular Ultrasound Guidance for Drug-Eluting Stent Implantation trial is a randomised, investigator-initiated, multicentre, open-label, non-inferiority trial comparing the quantitative coronary angiography (QCA)-guided PCI strategy with IVUS-guided PCI in all-comer patients with significant coronary artery disease. A novel, standardised, QCA-based PCI protocol for the QCA-guided group will be provided to all participating operators, while the PCI optimisation criteria will be predefined for both strategies. A total of 1528 patients will be randomised to either group at a 1:1 ratio. The primary endpoint is the 12-month cumulative incidence of target-lesion failure defined as a composite of cardiac death, target-vessel myocardial infarction or ischaemia-driven target-lesion revascularisation. Clinical follow-up assessments are scheduled at 1, 6 and 12 months for all patients enrolled in the study. Ethics and dissemination Ethics approval for this study was granted by the Institutional Review Board of Asan Medical Center (no. 2017-0060). Informed consent will be obtained from every participant. The study findings will be published in peer-reviewed journal articles and disseminated through public forums and academic conference presentations. Cost-effectiveness and secondary imaging analyses will be shared in secondary papers.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Clinical Impact of Intravascular Ultrasound Guidance in Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Disease Pooled Analysis at the Patient-Level of 4 Registries
    de la Torre Hernandez, Jose M.
    Baz Alonso, Jose A.
    Gomez Hospital, Joan A.
    Alfonso Manterola, Fernando
    Garcia Camarero, Tamara
    Gimeno de Carlos, Federico
    Roura Ferrer, Gerard
    Sanchez Recalde, Angel
    Lozano Martinez-Luengas, Inigo
    Gomez Lara, Josep
    Hernandez Hernandez, Felipe
    Perez-Vizcayno, Maria J.
    Cequier Fillat, Angel
    Perez de Prado, Armando
    Albarran Gonzalez-Trevilla, Agustin
    Jimenez Navarro, Manuel F.
    Mauri Ferre, Josepa
    Fernandez Diaz, Jose A.
    Pinar Bermudez, Eduardo
    Zueco Gil, Javier
    JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (03) : 244 - 254
  • [22] Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial
    Pilgrim, Thomas
    Heg, Dik
    Roffi, Marco
    Tuller, David
    Muller, Olivier
    Vuilliomenet, Andre
    Cook, Stephane
    Weilenmann, Daniel
    Kaiser, Christoph
    Jamshidi, Peiman
    Fahrni, Therese
    Moschovitis, Aris
    Noble, Stephane
    Eberli, Franz R.
    Wenaweser, Peter
    Juni, Peter
    Windecker, Stephan
    LANCET, 2014, 384 (9960) : 2111 - 2122
  • [23] Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial
    Jensen, Lisette Okkels
    Maeng, Michael
    Thayssen, Per
    Villadsen, Anton
    Krusell, Lars
    Botker, Hans Erik
    Pedersen, Knud Erik
    Aaroe, Jens
    Christiansen, Evald Hoej
    Vesterlund, Thomas
    Hansen, Knud Noerregaard
    Ravkilde, Jan
    Tilsted, Hans Henrik
    Lassen, Jens Flensted
    Thuesen, Leif
    EUROINTERVENTION, 2011, 7 (03) : 323 - 331
  • [24] Meta-analysis and systematic review of intravascular ultrasound versus angiography-guided drug eluting stent implantation in left main coronary disease in 4592 patients
    Wang, Yue
    Mintz, Gary S.
    Gu, Zhichun
    Qi, Yue
    Wang, Yue
    Liu, Mengru
    Wu, Xiaofan
    BMC CARDIOVASCULAR DISORDERS, 2018, 18
  • [25] Angiographic and clinical comparisons of intravascular ultrasound- versus angiography-guided drug-eluting stent implantation for patients with chronic total occlusion lesions: two-year results from a randomised AIR-CTO study
    Tian, Nai-Liang
    Gami, Sandeep-Kumar
    Ye, Fei
    Zhang, Jun-Jie
    Liu, Zhi-Zhong
    Lin, Song
    Ge, Zhen
    Shan, Shou-Jie
    You, Wei
    Chen, Liang
    Zhang, Yao-Jun
    Mintz, Gary
    Chen, Shao-Liang
    EUROINTERVENTION, 2015, 10 (12) : 1409 - 1417
  • [26] Intravascular Ultrasound versus Angiography Guided Drug Eluting Stent Implantation in Patients with Left Main Coronary Artery Disease - A Systematic Review and Meta-Analysis
    Karim, Kevin
    Akbar, Mohammad Rizki
    Pramudyo, Miftah
    Martha, Januar Wibawa
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (01)
  • [27] Early vascular healing after neXt-generation drug-eluting stent implantation in Patients with non-ST Elevation acute Coronary syndrome based on optical coherence Tomography guidance and evaluation (EXPECT): study protocol for a randomized controlled trial
    Zhu, Yong-Xiang
    Liang, Li
    Parasa, Ramya
    Li, Zheng
    Li, Qian
    Chang, Shang
    Ma, Wen-Rui
    Feng, Si-Li
    Wang, Yang
    Xu, Bo
    Bourantas, Christos V.
    Zhang, Yao-Jun
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [28] Meta-analysis and systematic review of intravascular ultrasound versus angiography-guided drug eluting stent implantation in left main coronary disease in 4592 patients
    Yue Wang
    Gary S. Mintz
    Zhichun Gu
    Yue Qi
    Yue Wang
    Mengru Liu
    Xiaofan Wu
    BMC Cardiovascular Disorders, 18
  • [29] Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO Study
    Cortese, Bernardo
    Micheli, Andrea
    Picchi, Andrea
    Coppolaro, Amelia
    Bandinelli, Loria
    Severi, Silva
    Limbruno, Ugo
    HEART, 2010, 96 (16) : 1291 - 1296
  • [30] Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial
    Gil, Robert J.
    Bil, Jacek
    Grundeken, Maik J.
    Kern, Adam
    Inigo Garcia, Luis A.
    Vassilev, Dobrin
    Pawlowski, Tomasz
    Formuszewicz, Radoslaw
    Dobrzycki, Slawomir
    Wykrzykowska, Joanna J.
    Serruys, Patrick W.
    EUROINTERVENTION, 2016, 12 (11) : E1404 - E1412